Market Overview:
The global implantable ventricular assist devices (IVADs) market is expected to reach USD 2.5 billion by 2030, registering a CAGR of 7.8% during the forecast period 2018-2030. The growth in the market can be attributed to factors such as rising prevalence of heart failure, technological advancements in IVADs, and increasing number of clinical trials for IVADs. Based on type, the global implantable ventricular assist devices (IVADs) market is segmented into left ventricular assist devices (LVADS), right ventricular assist devices (RVADS), and biventricular assistance devices (BIVADS). LVADS held a dominant position in the market in 2017 and is expected to maintain its dominance during the forecast period. This can be attributed to rising prevalence of heart failure across the globe and technological advancements in LVADS such as introduction of miniaturized LVAD systems that are less invasive and easier to implant. RVADS are expected to grow at a higher CAGR during 2018-2030 owing to increasing awareness about their benefits among patients with right heart failure caused due to various reasons such as myocardial infarction or valvular diseases.
Product Definition:
An implantable ventricular assist device (VAD) is a battery-operated, mechanical pump that helps pump blood from the left ventricle of your heart to the rest of your body. An implantable VAD is often used as a temporary measure for people who are waiting for a heart transplant.
LVADs:
It results in reduced blood flow and oxygen supply to the brain, which causes mental impairment and eventually death. LVADs are used as a last resort for people suffering from end-stage liver disease with no other treatment options available to them. The devices have been approved by the U.
RVADs:
RVADs are used in cases where the patient has suffered a brain injury and is unable to recover naturally. In such cases, an implantable device is used to provide electrical stimulation to the brain in order to help it heal itself. RVADs are also known as Brain Computer Interfaces (BCIs). They work by detecting and tracking the patient’s movements through sensors placed on or near their scalp.
Application Insights:
Bridge-to-transplant (BTT) held the largest share of over 50.0% in 2017. This is due to the increasing number of patients with end-stage heart failure and advanced cardiac life support devices as bridge to transplantation are being used globally. In addition, destination therapy segment is expected to witness lucrative CAGR during the forecast period owing to growing awareness about late diagnosis and treatment acceptance for advanced stages of Heart Failure (HF).
The other segment includes surgical procedures that require a ventricular assist device for recovery time post surgery. The procedure requires a patient who has suffered from brain injury or stroke resulting in loss of consciousness or paralysis on one side of body as well as face muscles on other side which makes it difficult for them communicate using their mouth muscles hence they need an implantable voice synthesizer system called Communication Assistance Device (CAD).
Regional Analysis:
North America dominated the global market in 2017. The presence of well-developed healthcare infrastructure, favorable government initiatives, and high awareness levels among individuals are some factors responsible for its large share. Moreover, increasing demand for heart failure treatment due to growing geriatric population is expected to drive growth during the forecast period.
Asia Pacific region is anticipated to witness lucrative growth over the forecast period owing to rising disposable income and improving healthcare facilities in emerging economies such as India and China. Furthermore, a rise in target patient population base with increased life expectancy will boost demand further during the same period. In addition, an increase in public & private partnerships between various organizations such as International Society for Pharmacoeconomics Research (ISPOR) and World Heart Federation (WHF) will help boost awareness about these devices leading to higher adoption rates across this region subsequently driving revenue generation over the next seven years (until 2030).
Growth Factors:
- Increasing prevalence of heart failure: The global prevalence of heart failure is expected to increase from 26 million in 2011 to over 40 million by 2030. This will create a large pool of patients who will require treatment, including implantable ventricular assist devices (VADs).
- Advances in technology: The development of smaller and more powerful implantable VADs has made them increasingly accessible to a wider range of patients. Additionally, advances in surgical techniques have made the procedure for implanting these devices less invasive, which is also contributing to their growing popularity.
- Growing awareness about the benefits of implantable VADs: There is growing awareness among both physicians and patients about the benefits offered by implantable VADs, such as improved quality of life and increased survival rates. This is helping to drive demand for these devices worldwide.
- Rising healthcare expenditure: Globally, healthcare expenditure is increasing at a rapid rate due to factors such as population growth and aging populations. This is providing greater funding for medical treatments such as implantable VAD therapy, which are helping to fuel market growth."
Scope Of The Report
Report Attributes
Report Details
Report Title
Implantable Ventricular Assist Devices Market Research Report
By Type
LVADs, RVADs, BIVADs
By Application
Bridge-to-transplant (BTT), Destination Therapy (DT), Other
By Companies
AbioMed, Abbott, Medtronic, Berlin Heart, Jarvik Heart Inc., Sun Medical Technology Research, ReliantHeart Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
221
Number of Tables & Figures
155
Customization Available
Yes, the report can be customized as per your need.
Global Implantable Ventricular Assist Devices Market Report Segments:
The global Implantable Ventricular Assist Devices market is segmented on the basis of:
Types
LVADs, RVADs, BIVADs
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Bridge-to-transplant (BTT), Destination Therapy (DT), Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AbioMed
- Abbott
- Medtronic
- Berlin Heart
- Jarvik Heart Inc.
- Sun Medical Technology Research
- ReliantHeart Inc.
Highlights of The Implantable Ventricular Assist Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- LVADs
- RVADs
- BIVADs
- By Application:
- Bridge-to-transplant (BTT)
- Destination Therapy (DT)
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Implantable Ventricular Assist Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Some of the key players operating in the implantable ventricular assist devices market are AbioMed, Abbott, Medtronic, Berlin Heart, Jarvik Heart Inc., Sun Medical Technology Research, ReliantHeart Inc..
The implantable ventricular assist devices market is expected to register a CAGR of 7.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Implantable Ventricular Assist Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Implantable Ventricular Assist Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Implantable Ventricular Assist Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Implantable Ventricular Assist Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Implantable Ventricular Assist Devices Market Size & Forecast, 2018-2028
4.5.1 Implantable Ventricular Assist Devices Market Size and Y-o-Y Growth
4.5.2 Implantable Ventricular Assist Devices Market Absolute $ Opportunity
Chapter 5 Global Implantable Ventricular Assist Devices Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Implantable Ventricular Assist Devices Market Size Forecast by Type
5.2.1 LVADs
5.2.2 RVADs
5.2.3 BIVADs
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Implantable Ventricular Assist Devices Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Implantable Ventricular Assist Devices Market Size Forecast by Applications
6.2.1 Bridge-to-transplant (BTT)
6.2.2 Destination Therapy (DT)
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Implantable Ventricular Assist Devices Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Implantable Ventricular Assist Devices Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Implantable Ventricular Assist Devices Analysis and Forecast
9.1 Introduction
9.2 North America Implantable Ventricular Assist Devices Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Implantable Ventricular Assist Devices Market Size Forecast by Type
9.6.1 LVADs
9.6.2 RVADs
9.6.3 BIVADs
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Implantable Ventricular Assist Devices Market Size Forecast by Applications
9.10.1 Bridge-to-transplant (BTT)
9.10.2 Destination Therapy (DT)
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Implantable Ventricular Assist Devices Analysis and Forecast
10.1 Introduction
10.2 Europe Implantable Ventricular Assist Devices Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Implantable Ventricular Assist Devices Market Size Forecast by Type
10.6.1 LVADs
10.6.2 RVADs
10.6.3 BIVADs
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Implantable Ventricular Assist Devices Market Size Forecast by Applications
10.10.1 Bridge-to-transplant (BTT)
10.10.2 Destination Therapy (DT)
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Implantable Ventricular Assist Devices Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Implantable Ventricular Assist Devices Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Implantable Ventricular Assist Devices Market Size Forecast by Type
11.6.1 LVADs
11.6.2 RVADs
11.6.3 BIVADs
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Implantable Ventricular Assist Devices Market Size Forecast by Applications
11.10.1 Bridge-to-transplant (BTT)
11.10.2 Destination Therapy (DT)
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Implantable Ventricular Assist Devices Analysis and Forecast
12.1 Introduction
12.2 Latin America Implantable Ventricular Assist Devices Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Implantable Ventricular Assist Devices Market Size Forecast by Type
12.6.1 LVADs
12.6.2 RVADs
12.6.3 BIVADs
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Implantable Ventricular Assist Devices Market Size Forecast by Applications
12.10.1 Bridge-to-transplant (BTT)
12.10.2 Destination Therapy (DT)
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Implantable Ventricular Assist Devices Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Implantable Ventricular Assist Devices Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Implantable Ventricular Assist Devices Market Size Forecast by Type
13.6.1 LVADs
13.6.2 RVADs
13.6.3 BIVADs
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Implantable Ventricular Assist Devices Market Size Forecast by Applications
13.10.1 Bridge-to-transplant (BTT)
13.10.2 Destination Therapy (DT)
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Implantable Ventricular Assist Devices Market: Competitive Dashboard
14.2 Global Implantable Ventricular Assist Devices Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AbioMed
14.3.2 Abbott
14.3.3 Medtronic
14.3.4 Berlin Heart
14.3.5 Jarvik Heart Inc.
14.3.6 Sun Medical Technology Research
14.3.7 ReliantHeart Inc.
